home All News open_in_new Full Article

Taiwan FDA Approves Nivolumab/Ipilimumab for MSI

Taiwan FDA Approves Nivolumab/Ipilimumab for MSI-H/dMMR Metastatic CRC  CancerNetwork


today 4 d. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 2775333970
Add Watch Country

arrow_drop_down